Skip to main content

Table 4 Summary of HCMV-tetramer in HLA-A24 young children

From: Large scale analysis of pediatric antiviral CD8+ T cell populations reveals sustained, functional and mature responses

Age(yr.) (n = 202) < 1 (n = 66) 1 (n = 46) 2 (n = 38) 3 (n = 25) 4 (n = 27)
Number of tet(+) 11(17%) 11(24%) 7(18%) 4(16%) 6(22%)
CD8 17.0 ± 5.0 20.0 ± 6.9 19.2 ± 4.2 22.3 ± 3.8 24.8 ± 5.6
Tet(%) 0.07 ± 0.08 0.05 ± 0.05 0.06 ± 0.10 0.01 ± 0 0.03 ± 0.03
Tet/CD8(%) 0.34 ± 0.32* 0.16 ± 0.15* 0.28 ± 0.55* 0.05 ± 0.01* 0.11 ± 0.12
  1. HCMV-tetramer positive: Tet/CD8(+) Lymphocytes ≥ 0.04%
  2. *: P values < 0.05